Quick Takeaways: Why It Matters? The deal broadens PetIQ’s product mix into a higher-value mobility category that can be cross-sold through retail, e-commerce and distribution channels, potentially increasing average basket size and strengthening PetIQ’s positioning as a branded pet health...
Quick Takeaways: Why It Matters? By terminating the PrecisePRP arrangement with VetStem, PetVivo removes outstanding invoices, royalties and milestone overhangs from a non-core product line, which should simplify the story for investors and management while freeing attention and capital fo...
Quick Takeaways: Why It Matters? LIMPID’s acquisition of PetPeotalk turns Kinfora into a richer, behaviour‑driven pet health platform, because it brings in a mature vision‑AI stack (Dogibogi) with real‑world scale, hundreds of millions of labelled behaviour ...
Quick Takeaways: Why It Matters? Zoetis’s Portela launch should expand the feline OA market by turning a hard-to-manage, underdiagnosed condition into a more actionable treatment segment, especially because the therapy offers a three-month injectable option that is easier for owners to kee...
Quick Takeaways: Why It Matters? Credelio Quattro appears to have a clear speed-of-kill advantage over Simparica Trio and NexGard Plus, with the studies showing faster and more sustained tick kill through the full monthly dosing interval. That matters because quicker tick death lowers the ...
Quick Takeaways: Why It Matters? CVS’s move to dispense pet prescriptions at roughly 9,000 pharmacies effectively turns it into a mass‑market veterinary pharmacy, expanding access to common dog and cat medications and creating a new recurring revenue stream built on refills, syncing, and e...
Quick Takeaways: Why It Matters? Zoetis’s launch of Lenivia (izenivetmab) in Canada and the EU introduces the first long-acting monoclonal antibody for canine osteoarthritis that binds a different NGF site than existing anti‑NGF therapies, offering up to three months of pain relief from a ...
Quick Takeaways: Why It Matters? Royal Canin’s Fresh Veterinary Diets give veterinarians a fresh, fully cooked therapeutic option in a fast-growing US therapeutic dog food market, aligning medical nutrition with owner demand for “fresh” feeding and strengthening Royal Canin’s position agai...
Quick Takeaways: Why It Matters? Tevra’s expansion of the Vetality First Aid Collection pushes more vet‑style OTC care into mainstream retail, making it easier for pet owners to treat common problems quickly at home and likely increasing self-care product sales and category growth at Walma...
Quick Takeaways: Why It Matters? Zoetis’s acquisition of VitalRADS is a strategic move to consolidate and scale veterinary diagnostics by bundling AI-powered workflow tools, teleradiology, mobile and outpatient imaging, and cloud-based storage under one platform, which should a...
